| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Richard Volckmann
|
|||||||
| GSE254946 |
Esophageal adenocarcinoma
|
106 | Richard Volckmann | May 25, 2024 | ||||
| GSE254942 |
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma
|
106 | Richard Volckmann | May 15, 2024 | ||||
| GSE125057 |
Mesenchymal (MES)- and Adrenergic (ADN) neuroblastoma cell line pair of isogenic origin
|
3 | Richard Volckmann | Oct 01, 2021 | ||||
| GSE125058 |
Xenograft tumors of neuroblastoma cell lines
|
6 | Richard Volckmann | Oct 01, 2021 | ||||
| GSE125059 |
Neuroblastoma cell lines
|
15 | Richard Volckmann | Oct 01, 2021 | ||||
| GSE126054 |
Neuroblastoma is composed of two super enhancer-associated differentiation states [ChIP-seq]
|
6 | Richard Volckmann | Oct 01, 2021 | ||||
| GSE120938 |
Expression data of the human multiple myeloma cell line XG-3 after AKT inhibition in a FOXO3 deficient background
|
8 | Richard Volckmann | Sep 02, 2020 | ||||
| GSE120939 |
Expression data of the human multiple myeloma cell line MM1.S after AKT inhibition in a FOXO3 deficient background
|
8 | Richard Volckmann | Sep 02, 2020 | ||||
| GSE120940 |
Expression data of the human multiple myeloma cell line LME-1 after AKT inhibition in a FOXO1 deficient background
|
8 | Richard Volckmann | Sep 02, 2020 | ||||
| GSE120941 |
FOXO1 and FOXO3
|
24 | Richard Volckmann | Sep 02, 2020 | ||||
| GSE102189 |
Transcriptional profiling of OT-1 cells during in vitro memory formation after high- or low-affinity priming
|
24 | Richard Volckmann | Jan 06, 2020 | ||||
| GSE106388 |
Enhanced interferon response genes in bronchial epithelial cells after in vivo rhinovirus challenge of asthma patients
|
38 | Richard Volckmann | Jan 06, 2020 | ||||
| GSE129238 |
Differential c-Kit expression identifies two subsets of ILC2s with IL-17 producing capabilities that may contribute to IL-17 mediated pathologies
|
18 | Richard Volckmann | Jun 29, 2019 | ||||
| GSE129980 |
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
|
4 | Richard Volckmann | Apr 18, 2019 | ||||
| GSE116890 |
Time-course inducible NOTCH3-IC expression in SH-SY5Y.
|
9 | Richard Volckmann | Apr 04, 2019 | ||||
| GSE116891 |
Reversible induction NOTCH3-IC in SH-SY5Y.
|
5 | Richard Volckmann | Apr 04, 2019 | ||||
| GSE116892 |
Xenograft SH-SY5Y tumors with inducible NOTCH3-IC expression.
|
8 | Richard Volckmann | Apr 04, 2019 | ||||
| GSE116893 |
NOTCH3-IC
|
26 | Richard Volckmann | Apr 04, 2019 | ||||
| GSE115406 |
Generating a RAS expression signature in neuroblastoma
|
18 | Richard Volckmann | Aug 22, 2018 | ||||
| GSE97781 |
Chemotherapy recurrence colon cancer spheroid L145
|
15 | Richard Volckmann | Aug 01, 2018 |
